Contact Information
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
PediatricsCardiology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Kan N. Hor
Biography
Kan N. Hor, MD, pediatric cardiologist, is the director of Cardiac MRI at The Heart Center at Nationwide Children's Hospital and an associate professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Hor received his medical degree from University of Illinois-COM, Chicago and completed his pediatric internship and residency at Children's Hospital of Wisconsin, Milwaukee. Dr. Hor continued his training and completed his pediatric fellowship training at Cincinnati Children's Hospital Medical Center. Dr. Hor completed an additional advanced cardiac imaging fellowship at Cincinnati Children's Hospital with a focus on cardiac MRI. Dr. Hor's clinical interests include cardiac MRI, cardiac CT angiography, echocardiography (TTE and TEE) and congenital heart disease. His academic research interest includes cardiac MRI and echocardiography and its application for analysis of cardiac strain and synchrony in Duchenne Muscular Dystrophy, heart failure and congenital heart disease. Dr. Hor collaborates with many other researchers around the globe and is board certified in both pediatrics and pediatric cardiology.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Heart Center
Physician Team
Cardiology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Cardiology
Awards, Honors & Organizations
Listed, Best Doctors in America
Research
Publications
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 01/02/2013
Board Certifications
Pediatric Cardiology
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2007
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2006
Residency
Children’s Hospital of Wisconsin
Date Completed: 06/30/2003
Medical School
University of Illinois at Chicago School of Public
Date Completed: 05/01/2000
Contact Information
Pediatrics
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
PediatricsCardiology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Kan N. Hor
Biography
Kan N. Hor, MD, pediatric cardiologist, is the director of Cardiac MRI at The Heart Center at Nationwide Children's Hospital and an associate professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Hor received his medical degree from University of Illinois-COM, Chicago and completed his pediatric internship and residency at Children's Hospital of Wisconsin, Milwaukee. Dr. Hor continued his training and completed his pediatric fellowship training at Cincinnati Children's Hospital Medical Center. Dr. Hor completed an additional advanced cardiac imaging fellowship at Cincinnati Children's Hospital with a focus on cardiac MRI. Dr. Hor's clinical interests include cardiac MRI, cardiac CT angiography, echocardiography (TTE and TEE) and congenital heart disease. His academic research interest includes cardiac MRI and echocardiography and its application for analysis of cardiac strain and synchrony in Duchenne Muscular Dystrophy, heart failure and congenital heart disease. Dr. Hor collaborates with many other researchers around the globe and is board certified in both pediatrics and pediatric cardiology.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Heart Center
Physician Team
Cardiology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Cardiology
Awards, Honors & Organizations
Listed, Best Doctors in America
Research
Publications
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 01/02/2013
Board Certifications
Pediatric Cardiology
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2007
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2006
Residency
Children’s Hospital of Wisconsin
Date Completed: 06/30/2003
Medical School
University of Illinois at Chicago School of Public
Date Completed: 05/01/2000
Contact Information
Pediatrics
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
PediatricsCardiology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Kan N. Hor
Contact Information
- Call us at:
- (614) 722-2530
- Fax us at:
- (614) 722-2549
- PediatricsCardiology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Kan N. Hor
Biography
Kan N. Hor, MD, pediatric cardiologist, is the director of Cardiac MRI at The Heart Center at Nationwide Children's Hospital and an associate professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Hor received his medical degree from University of Illinois-COM, Chicago and completed his pediatric internship and residency at Children's Hospital of Wisconsin, Milwaukee. Dr. Hor continued his training and completed his pediatric fellowship training at Cincinnati Children's Hospital Medical Center. Dr. Hor completed an additional advanced cardiac imaging fellowship at Cincinnati Children's Hospital with a focus on cardiac MRI. Dr. Hor's clinical interests include cardiac MRI, cardiac CT angiography, echocardiography (TTE and TEE) and congenital heart disease. His academic research interest includes cardiac MRI and echocardiography and its application for analysis of cardiac strain and synchrony in Duchenne Muscular Dystrophy, heart failure and congenital heart disease. Dr. Hor collaborates with many other researchers around the globe and is board certified in both pediatrics and pediatric cardiology.
Biography
Kan N. Hor, MD, pediatric cardiologist, is the director of Cardiac MRI at The Heart Center at Nationwide Children's Hospital and an associate professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Hor received his medical degree from University of Illinois-COM, Chicago and completed his pediatric internship and residency at Children's Hospital of Wisconsin, Milwaukee. Dr. Hor continued his training and completed his pediatric fellowship training at Cincinnati Children's Hospital Medical Center. Dr. Hor completed an additional advanced cardiac imaging fellowship at Cincinnati Children's Hospital with a focus on cardiac MRI. Dr. Hor's clinical interests include cardiac MRI, cardiac CT angiography, echocardiography (TTE and TEE) and congenital heart disease. His academic research interest includes cardiac MRI and echocardiography and its application for analysis of cardiac strain and synchrony in Duchenne Muscular Dystrophy, heart failure and congenital heart disease. Dr. Hor collaborates with many other researchers around the globe and is board certified in both pediatrics and pediatric cardiology.
Biography
Kan N. Hor, MD, pediatric cardiologist, is the director of Cardiac MRI at The Heart Center at Nationwide Children's Hospital and an associate professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Hor received his medical degree from University of Illinois-COM, Chicago and completed his pediatric internship and residency at Children's Hospital of Wisconsin, Milwaukee. Dr. Hor continued his training and completed his pediatric fellowship training at Cincinnati Children's Hospital Medical Center. Dr. Hor completed an additional advanced cardiac imaging fellowship at Cincinnati Children's Hospital with a focus on cardiac MRI. Dr. Hor's clinical interests include cardiac MRI, cardiac CT angiography, echocardiography (TTE and TEE) and congenital heart disease. His academic research interest includes cardiac MRI and echocardiography and its application for analysis of cardiac strain and synchrony in Duchenne Muscular Dystrophy, heart failure and congenital heart disease. Dr. Hor collaborates with many other researchers around the globe and is board certified in both pediatrics and pediatric cardiology.
Kan N. Hor, MD, pediatric cardiologist, is the director of Cardiac MRI at The Heart Center at Nationwide Children's Hospital and an associate professor of Clinical Pediatrics at The Ohio State University College of Medicine. Dr. Hor received his medical degree from University of Illinois-COM, Chicago and completed his pediatric internship and residency at Children's Hospital of Wisconsin, Milwaukee. Dr. Hor continued his training and completed his pediatric fellowship training at Cincinnati Children's Hospital Medical Center. Dr. Hor completed an additional advanced cardiac imaging fellowship at Cincinnati Children's Hospital with a focus on cardiac MRI. Dr. Hor's clinical interests include cardiac MRI, cardiac CT angiography, echocardiography (TTE and TEE) and congenital heart disease. His academic research interest includes cardiac MRI and echocardiography and its application for analysis of cardiac strain and synchrony in Duchenne Muscular Dystrophy, heart failure and congenital heart disease. Dr. Hor collaborates with many other researchers around the globe and is board certified in both pediatrics and pediatric cardiology.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
Locations
Main Campus of Nationwide Children’s Hospital
- Main Campus of Nationwide Children’s Hospital
Academic and Clinical Areas
Heart Center
Physician Team
Cardiology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Cardiology
Academic and Clinical Areas
Heart Center
Physician Team
Cardiology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Cardiology
Academic and Clinical Areas
Heart Center
Physician Team
Cardiology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Cardiology
Heart Center
Physician Team
Cardiology Fellowship
Faculty
Primary Department
Pediatrics
Primary Section
Cardiology
- Heart Center
- Physician Team
- Cardiology Fellowship
- Faculty
- Primary Department
- Pediatrics
- Primary Section
- Cardiology
Awards, Honors & Organizations
Listed, Best Doctors in America
Awards, Honors & Organizations
Listed, Best Doctors in America
Awards, Honors & Organizations
Listed, Best Doctors in America
Listed, Best Doctors in America
- Listed, Best Doctors in America
Research
Publications
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
View More Publications
Research
Publications
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
View More Publications
Research
Publications
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
View More Publications
Publications
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
View More Publications
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin'oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
View More Publications
- McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J, PRO-DMD-01 consortium investigators. Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1. J Neuromuscul Dis. 2022 Dec 19;
- McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L, HOPE-2 Study Group.. Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 Mar 12; 399: 1049-1058.
- Blum KM, Zbinden JC, Ramachandra AB, Lindsey SE, Szafron JM, Reinhardt JW, Heitkemper M, Best CA, Mirhaidari GJM, Chang YC, Ulziibayar A, Kelly J, Shah KV, Drews JD, Zakko J, Miyamoto S, Matsuzaki Y, Iwaki R, Ahmad H, Daulton R, Musgrave D, Wiet MG, Heuer E, Lawson E, Schwarz E, McDermott MR, Krishnamurthy R, Krishnamurthy R, Hor K, Armstrong AK, Boe BA, Berman DP, Trask AJ, Humphrey JD, Marsden AL, Shinoka T, Breuer CK. Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth. Commun Med (Lond). 2022; 2: 3.
- Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscul Disord. 2021 Oct 10;
- Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin’oka T, Marsden AL, Breuer CK. Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Aug 12; 6: 47.
- Schwarz EL, Kelly JM, Blum KM, Hor KN, Yates AR, Zbinden JC, Verma A, Lindsey SE, Ramachandra AB, Szafron JM, Humphrey JD, Shin’oka T, Marsden AL, Breuer CK. Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients. NPJ Regen Med. 2021 Jul 22; 6: 38.
- Lee S, Lee M, Hor KN. The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy. Pediatr Pulmonol. 2021 Apr; 56: 766-781.
- Spurney CF, Ascheim D, Charnas L, Cripe L, Hor K, King N, Kinnett K, McNally EM, Sauer JM, Sweeney L, Villa C, Markham LW. Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel. Open Heart. 2021 Mar; 8:
- Jackson JL, Korth CX, Leslie CE, Cotto J, Mah ML, Hor K, Cripe L, Al-Zaidy S, Camino EM, Church K, Lehman KJ, Shay V, Mendell JR. Health-Related Quality of Life and Emotional Distress Among Mothers of Sons With Muscular Dystrophy as Compared to Sex- and Age Group-Matched Controls. J Child Neurol. 2021 Mar; 36: 177-185.
- Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP. Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics. 2019 Jun; 143:
- Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B. A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol. 2019 May; 41: e206-e209.
- Sharma R, Woods GM, Creary S, O’Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer. 2019 Apr; 66: e27588.
- Wilhelm CM, Hickey J, McConnell P, Hor KN, Mah ML. Ventricular Dysfunction in a 40-Year-Old With Coronary Compression From Aortic Aneurysm Following Waterston Shunt and Complete Repair of Tetralogy of Fallot. CASE (Phila). 2019 Apr; 3: 44-45.
- Soslow JH, Hall M, Burnette WB, Hor K, Chisolm J, Spurney C, Godown J, Xu M, Slaughter JC, Markham LW. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity. Cardiol Young. 2019 Mar; 29: 290-296.
- Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Cardiac Management of the Patient With Duchenne Muscular Dystrophy. Pediatrics. 2018 Oct; 142: S72-S81.
- Hor KN, Mah ML, Johnston P, Cripe TP, Cripe LH. Advances in the diagnosis and management of cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul Disord. 2018 Sep; 28: 711-716.
- Oatmen KE, Toro-Salazar OH, Hauser K, Zellars KN, Mason KC, Hor K, Gillan E, Zeiss CJ, Gatti DM, Spinale FG. Identification of a Novel microRNA Profile in Pediatric Cancer Patients treated with Anthracycline Chemotherapy. Am J Physiol Heart Circ Physiol. 2018 Aug 24;
- Best C, Fukunishi T, Drews J, Khosravi R, Hor K, Mahler N, Yi T, Humphrey JD, Johnson J, Breuer CK, Hibino N. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 Aug; 24: 1251-1261.
- Toro-Salazar OH, Lee JH, Zellars KN, Perreault PE, Mason KC, Wang Z, Hor KN, Gillan E, Zeiss CJ, Gatti DM, Davey BT, Kutty S, Liang BT, Spinale FG. Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines. Cardiooncology. 2018; 4:
- Best C, Strouse R, Hor K, Pepper V, Tipton A, Kelly J, Shinoka T, Breuer C. Toward a patient-specific tissue engineered vascular graft. J Tissue Eng. 2018 Jan-Dec; 9: 2041731418764709.
Education
Date of Appointment at Nationwide Children’s Hospital: 01/02/2013
Board Certifications
Pediatric Cardiology
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2007
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2006
Residency
Children’s Hospital of Wisconsin
Date Completed: 06/30/2003
Medical School
University of Illinois at Chicago School of Public
Date Completed: 05/01/2000
Education
Date of Appointment at Nationwide Children’s Hospital: 01/02/2013
Board Certifications
Pediatric Cardiology
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2007
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2006
Residency
Children’s Hospital of Wisconsin
Date Completed: 06/30/2003
Medical School
University of Illinois at Chicago School of Public
Date Completed: 05/01/2000
Education
Date of Appointment at Nationwide Children’s Hospital: 01/02/2013
Board Certifications
Pediatric Cardiology
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2007
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2006
Residency
Children’s Hospital of Wisconsin
Date Completed: 06/30/2003
Medical School
University of Illinois at Chicago School of Public
Date Completed: 05/01/2000
Date of Appointment at Nationwide Children’s Hospital: 01/02/2013
Board Certifications
Pediatric Cardiology
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2007
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2006
Residency
Children’s Hospital of Wisconsin
Date Completed: 06/30/2003
Medical School
University of Illinois at Chicago School of Public
Date Completed: 05/01/2000
Date of Appointment at Nationwide Children’s Hospital: 01/02/2013
Board Certifications
Pediatric Cardiology
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2007
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/2006
Residency
Children’s Hospital of Wisconsin
Date Completed: 06/30/2003
Medical School
University of Illinois at Chicago School of Public
Date Completed: 05/01/2000
- Pediatric Cardiology
Contact Information
Pediatrics
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-2530
Fax us at: (614) 722-2549
Cardiology700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-2530
- Fax us at:
- (614) 722-2549
- Cardiology700 Children’s DrColumbus, OH 43205 (map)
